Award-winning Biotechnology Company Developing Sustainable Construction Materials

Expressions of Interest By:

Wednesday 10 June 2026, 2:00pm BST



DOWNLOAD NDA

Hilco is delighted to offer for sale the business and assets of an award-winning biotechnology company that has developed high-performance building insulation materials via the transformation of waste and filament root structures through proprietary biofabrication processes.

Business Highlights

  • Extensive experience in regenerative materials, circular manufacturing and biomimetic technologies.
  • Approximately £9m of investment received to date to support 10 years of deep-tech R&D.
  • Proprietary insulation material with demonstrated performance in energy consumption, fire safety, produced carbon emissions and energy consumption.
  • Opportunity for a wide range of applications across business sectors and markets.
  • Highly scalable material and technology with a potentially global marketplace

Company Assets

The Valuable Intellectual Property Comprising: 

  • Patents – A comprehensive portfolio of four patent families across multiple jurisdictions
  • Trademarks and Brand Name – Established trademark protected brand name and associated brand capital
  • Organisational Knowledge and Know-How – The considerable knowledge developed on composite materials, biofabrication systems, manufacturing processes, and substrate formulations
  • R&D– The extensive R&D in materials, processes and product ranges
  • Digital Assets – The Company domain names, website content and social media accounts

Sales Process and Further Information

The initial deadline for expressions of interest is Wednesday 10 June 2026, 2:00pm BST

A further bid deadline will be set following the initial expression of interest deadline.

On receipt of a signed non-disclosure agreement (NDA) access will be provided to a virtual data room housing additional information. To access the NDA please click the link, sign and return via email to [email protected]

Key Terms and Conditions

No warranties, express or implied, are provided in relation to any information or statements made in connection to this opportunity. The information contained herein, and within the project dataroom, has not been verified by Hilco and prospective purchasers must undertake their own due diligence to satisfy themselves as to the accuracy of all such information and any statements made. Hilco’s full Terms and Conditions apply.  Hilco acts as agent for the Vendor who offers for sale only such right, title and interest the Company possesses in the assets.

Contacts

Sophie Felstead

Analyst

London Office

+44 (0) 7394 802845

[email protected]

Roland Cramp MRICS

Managing Director

London Office

+44 (0) 7710 152668

[email protected]